Role of Clostridium difficile in antibiotic-associated pseudomembranous colitis.
about
Clostridium difficile toxins: mechanism of action and role in disease.Fulminant Clostridium difficile: an underappreciated and increasing cause of death and complicationsRifalazil treats and prevents relapse of clostridium difficile-associated diarrhea in hamstersToxigenic clostridiaClostridium difficile: its disease and toxinsSurgical Management of Clostridium difficile ColitisToxin B is essential for virulence of Clostridium difficileEffect of environmental stress on Clostridium difficile toxin levels during continuous cultivationEnzyme-linked immunosorbent assay for Clostridium difficile toxin AImportance of Glutamate Dehydrogenase (GDH) in Clostridium difficile Colonization In VivoAntimicrobial Resistance and Reduced Susceptibility in Clostridium difficile: Potential Consequences for Induction, Treatment, and Recurrence of C. difficile InfectionDiversity and Evolution in the Genome of Clostridium difficileInference of Network Dynamics and Metabolic Interactions in the Gut MicrobiomeRole of leptin-mediated colonic inflammation in defense against Clostridium difficile colitisImmune responses to Clostridium difficile infectionProlonged impact of antibiotics on intestinal microbial ecology and susceptibility to enteric Salmonella infectionToxin gene analysis of a variant strain of Clostridium difficile that causes human clinical disease.Typing of Clostridium difficile causing diarrhoea in an orthopaedic wardPseudomembranous colitis in a leukaemia unit: a report of five fatal cases.The role of toxin A and toxin B in Clostridium difficile-associated disease: Past and present perspectives.Antimicrobial agent-associated colitis and diarrhea.Macro and micro diversity of Clostridium difficile isolates from diverse sources and geographical locations.Clostridium difficile toxin B is more potent than toxin A in damaging human colonic epithelium in vitroClostridium difficile and the microbiotaInflammatory bowel disease associated circulating immune complexesUsing phenotype microarrays to determine culture conditions that induce or repress toxin production by Clostridium difficile and other microorganisms.The roles of host and pathogen factors and the innate immune response in the pathogenesis of Clostridium difficile infection.Clostridium difficile in association with sporadic diarrhoea.Clostridium difficile 027/BI/NAP1 encodes a hypertoxic and antigenically variable form of TcdB.Clostridium difficile-associated diarrhea after living donor liver transplantation.Clostridium difficile Infection and Inflammatory Bowel Disease: A Review.Transferable tetracycline resistance in Clostridium difficiletcdC genotypes associated with severe TcdC truncation in an epidemic clone and other strains of Clostridium difficile.Influence of antibiotics on intestinal tract survival and translocation of environmental Pseudomonas species.Pseudomembranous colitis: multiple relapses after treatment with metronidazoleEffects of antibiotics and other drugs on toxin production in Clostridium difficile in vitro and in vivoA Catalytic DNA Activated by a Specific Strain of Bacterial Pathogen.Models for the study of Clostridium difficile infection.Bacillus pumilus in the induction of clindamycin-associated enterocolitis in guinea pigsBiological activities of toxins A and B of Clostridium difficile
P2860
Q24522454-2D4E98C0-3909-4586-B61D-25448859A26EQ24542134-71F296EB-79A7-4D69-AC36-FA29F5692F88Q24563857-CB43E388-B412-4D9B-8DA3-584183B15586Q24616838-FA462F51-4A25-47C8-B2E4-1ECF3B128DBDQ24617347-A3733CDC-DDB3-4E2B-9C3E-8D8B574C508AQ24618413-31882588-60D9-4034-B978-464E9C3C722BQ24647539-62D74A96-A422-49FB-BEC0-9D1D388E5D83Q24651434-6E183083-3742-46DA-A1FD-E2B3F82CA1C4Q24652980-37439193-2115-42D3-8003-5573368B99CBQ27332358-8BDD4753-CC32-4C19-BB21-7A26F4B64BB8Q28084026-F5EF8952-8967-4932-A212-8210DA5D4CEBQ28084700-0D92900C-9CF0-4348-B079-7B547E76760CQ30384334-B3BF9A6B-7131-48D5-AE97-7CC3D6C8A2E9Q30412148-3796F2CE-7740-4470-A4DE-8A6A7B6C198DQ30416692-2DF26176-7FBF-4EA9-A7A4-0520994A4FCAQ33432484-3A1EF5AF-2E8F-4492-A38C-5BBF781E827DQ33590965-5E4C955E-ABEE-4884-AF66-E7C1B0E72E17Q33840098-7425A0D9-1C99-42A2-B6F3-13A77A3BC121Q33847707-30EF8853-E579-41BB-9905-EFDB6D782094Q34006236-DEE2990D-A393-45DC-B440-39D68D526041Q34108598-34DFDCBC-5027-475D-BC1C-4F2D5300E85FQ34187096-7B768553-25BD-4DD5-9F44-AEC18461B041Q34214675-818B08EF-4A81-4E32-87FF-3F1FAEBB5D38Q34311594-49633BC4-AA9D-48F8-975C-10F8A00201B1Q34496939-089103A3-1053-43DC-8307-B5859DFB4026Q34598906-EC93D64D-F5E5-4202-87EC-7A3E7CDBFC95Q34623572-D7B0CEC2-706F-4F0A-B2EF-38BEEBB601F0Q34747182-33109E36-0402-4354-8FCE-0480E34B9B96Q34916871-8BF0A0A0-A699-4DE9-8D2D-504030A670E0Q35055941-4D8F1ED7-AC56-411B-8D98-6F5479C5D46FQ35208564-DF799995-9B95-49A0-90EF-DBA73B9834B7Q35670616-B03353EA-C5C9-4036-A1B9-3D65BAA90B88Q35690283-0B3E415A-FFA7-4C8D-9F6D-653F75F21F52Q35738408-2EADC9E4-4969-46C6-A971-D6A436862509Q35776166-7D9ED6AF-0CF9-457E-98B3-5F9FAB8B7713Q35862930-385C6D09-A3D3-4628-A90A-45F69DCA2866Q35871196-8C2E96D8-2043-4028-9217-CEC541103D7BQ36019356-859F1A30-3600-4D9F-9BB5-002DE20578A6Q36434287-B2E485F4-020F-49AC-92D6-7371CA89A083Q36438279-89D11E32-2958-422E-8553-0FD8A35BFEF6
P2860
Role of Clostridium difficile in antibiotic-associated pseudomembranous colitis.
description
1978 nî lūn-bûn
@nan
1978年の論文
@ja
1978年論文
@yue
1978年論文
@zh-hant
1978年論文
@zh-hk
1978年論文
@zh-mo
1978年論文
@zh-tw
1978年论文
@wuu
1978年论文
@zh
1978年论文
@zh-cn
name
Role of Clostridium difficile in antibiotic-associated pseudomembranous colitis.
@en
type
label
Role of Clostridium difficile in antibiotic-associated pseudomembranous colitis.
@en
prefLabel
Role of Clostridium difficile in antibiotic-associated pseudomembranous colitis.
@en
P2093
P1433
P1476
Role of Clostridium difficile in antibiotic-associated pseudomembranous colitis.
@en
P2093
P304
P407
P577
1978-11-01T00:00:00Z